Skipping aspirin after MI tied to higher risk of recurrence and death
Danish researchers analysed long-term outcomes in 40,000 patients prescribed daily low-dose aspirin for secondary prevention.
Patients who stop taking daily low-dose aspirin after MI have up to a 40% higher risk of recurrent MI, stroke, or death than those who consistently take the drug, a registry-based study shows.
Danish researchers followed more than 40,000 people aged 40 or older who had a first-time MI from 2004-17.
The team checked aspirin use for secondary prevention at two, four, six and eight years after MI to see who was still taking daily aspirin regularly.
Those using anticoagulants or P2Y12 inhibitors were excluded from the analysis, by Dr Anna Meta Dyrvig Kristensen and colleagues, from Bispebjerg and Frederiksberg Hospital in Frederiksberg.
